SCHEMBL2553884

SCHEMBL2553884

CCN1CCC(N(C)S(=O)(=O)c2ccc(CNC3CCCC3)cc2)C1

nearest known ligand 0.50

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 10/20 0.50
HTR2C P28335 10/20 0.50
OPRM1 P35372 1/20 0.43
OPRK1 P41145 1/20 0.43
ALDH1A1 P00352 1/20 0.43
LMNA P02545 1/20 0.43
GAA P10253 1/20 0.43
LSS P48449 1/20 0.43
NAMPT P43490 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
HRH3 Q9Y5N1 2/20 0.41
FABP6 P51161 1/20 0.41
CCR5 P51681 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2549845 0.84 HTR2A (0.67) HTR2AHTR2CALDH1A1GAAL3MBTL1
SCHEMBL7716908 0.79 KDM4E (0.48) ALDH1A1LMNAGAANAMPTHRH3
SCHEMBL2555109 0.79 KDM4E (0.48) ALDH1A1LMNAGAANAMPTHRH3
SCHEMBL2547933 0.79 KDM4E (0.48) ALDH1A1LMNAGAANAMPTHRH3
Hydrochloric Acid SCHEMBL2552429 0.78 KDM4E (0.47) ALDH1A1LMNAGAANAMPTHRH3
Hydrochloric Acid SCHEMBL2552428 0.78 KDM4E (0.47) ALDH1A1LMNAGAANAMPTHRH3
SCHEMBL2555154 0.76 KDM4E (0.48) OPRM1OPRK1ALDH1A1LMNAGAA
SCHEMBL7716923 0.76 SMN1; SMN2 (0.54) ALDH1A1LMNAGAAHRH3FABP6
SCHEMBL2551564 0.76 HRH3 (0.45) OPRM1OPRK1ALDH1A1HRH3FABP6
SCHEMBL2553125 0.71 SMN1; SMN2 (0.47) ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011121309-A1 PHENYL SULFONYL DERIVATIVES AND THEIR USE AS HISTAMINE H3 ANTAGONISTS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-10-06 WO disclosed
WO-2011121309-A1 PHENYL SULFONYL DERIVATIVES AND THEIR USE AS HISTAMINE H3 ANTAGONISTS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-10-06 WO disclosed